These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6174009)

  • 1. Cellular growth in organs of dwarf mice during treatment with growth hormone, thyroxine and plasma fractions containing somatomedin activity.
    van Buul-Offers S; Van den Brande JL
    Acta Endocrinol (Copenh); 1982 Jan; 99(1):150-60. PubMed ID: 6174009
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of growth hormone and peptide fractions containing somatomedin activity on growth and cartilage metabolism of Snell dwarfmice.
    Van den Brande JL; van Buul-Offers S
    Acta Endocrinol (Copenh); 1979 Oct; 92(2):242-57. PubMed ID: 494990
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of growth hormone and thyroxine on renal development in Snell pituitary dwarf mice].
    Tokuda N
    Hinyokika Kiyo; 1995 Jun; 41(6):419-26. PubMed ID: 7544062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The bioassay of growth hormone in Snell's dwarf mice: effects of thyroxine and prolactin on the dose-response curve.
    Wallis M; Dew JA
    J Endocrinol; 1973 Feb; 56(2):235-43. PubMed ID: 4703239
    [No Abstract]   [Full Text] [Related]  

  • 5. Growth-stimulating effects of somatomedin-/insulin-like peptides in Snell dwarf mice.
    van Buul-Offers S; Hoogerbrugge CM; Branger J; Feijlbrief M; Van den Brande JL
    Horm Res; 1988; 29(5-6):229-36. PubMed ID: 3220460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Actions of growth hormone, prolactin and thyroxine on serum somatomedin-like activity and growth in hypopituitary dwarf mice.
    Holder AT; Wallis M
    J Endocrinol; 1977 Aug; 74(2):223-9. PubMed ID: 894170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular growth in several organs of normal and dwarfed Snell mice.
    van Buul-Offers S; Van den Brande JL
    Acta Endocrinol (Copenh); 1982 Jan; 99(1):141-9. PubMed ID: 6174008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of bovine growth hormone and a partially pure preparation of somatomedin on various growth parameters in hypopituitary dwarf mice.
    Holder AT; Spencer EM; Preece MA
    J Endocrinol; 1981 May; 89(2):275-82. PubMed ID: 7241014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fracture repair in the Snell dwarf mouse.
    Ashton IK; Dekel S
    Br J Exp Pathol; 1983 Oct; 64(5):479-86. PubMed ID: 6639868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of growth hormone, prolactin and thyroxine on body wegith, somatomedin-like activity and in-vivo sulphation of cartilage in hypopituitary dwarf mice.
    Holder AT; Wallis M; Biggs P; Preece MA
    J Endocrinol; 1980 Apr; 85(1):35-41. PubMed ID: 7391723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulphation factor activity and growth rate during long-term treatment of patients with pituitary dwarfism with human growth hormone.
    Hall K; Olin P
    Acta Endocrinol (Copenh); 1972 Mar; 69(3):417-33. PubMed ID: 5067009
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of hormones on development and function of lymphoid tissues. Synergistic action of thyroxin and somatotropic hormone in pituitary dwarf mice.
    Baroni CD; Fabris N; Bertoli G
    Immunology; 1969 Aug; 17(2):303-14. PubMed ID: 5804539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anabolic actions of growth hormone and thyroxine on protein metabolism in Snell dwarf and normal mice.
    Bates PC; Holder AT
    J Endocrinol; 1988 Oct; 119(1):31-41. PubMed ID: 3193047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of hormone treatment on chromosomal radiosensitivity of somatic and germ cells of Snell's dwarf mice.
    van Buul PP; van Buul-Offers SC
    Mutat Res; 1988 Apr; 198(2):263-8. PubMed ID: 3352633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormones and immunological capacity. II. Reconstitution of antibody production in hormonally deficient mice by somatotropic hormone, thyrotropic hormone and thyroxin.
    Pierpaoli W; Baroni C; Fabris N; Sorkin E
    Immunology; 1969 Feb; 16(2):217-30. PubMed ID: 5769978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone, somatomedins, and growth failure.
    Van Wyk JJ; Underwood LE
    Hosp Pract; 1978 Aug; 13(8):57-67. PubMed ID: 689681
    [No Abstract]   [Full Text] [Related]  

  • 17. [Current status of the growth hormone therapy in dwarfism].
    Shizume K
    Nihon Naibunpi Gakkai Zasshi; 1984 Dec; 60(12):1492-502. PubMed ID: 6529990
    [No Abstract]   [Full Text] [Related]  

  • 18. [Considerations of the clinical aspects and treatment of pituitary dwarfism].
    Cotellessa G
    Minerva Pediatr; 1976 May; 28(18):1081-2. PubMed ID: 1012179
    [No Abstract]   [Full Text] [Related]  

  • 19. Experiences with human growth hormone in pituitary dwarfism.
    Seip M; Trygstad O
    Acta Paediatr Scand; 1966 May; 55(3):287-93. PubMed ID: 5960341
    [No Abstract]   [Full Text] [Related]  

  • 20. Constancy of somatomedin response to growth hormone treatment of hypopituitary dwarfism, and lack of correlation with growth rate.
    Rosenfeld RG; Kemp SF; Hintz RL
    J Clin Endocrinol Metab; 1981 Sep; 53(3):611-7. PubMed ID: 7021582
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.